264 related articles for article (PubMed ID: 31009392)
21. Tumor cell nuclear diameter and CD30 expression as potential prognostic parameter in patients with extranodal NK/T-cell lymphoma, nasal type.
Hong J; Park S; Baek HL; Jung JH; Kang IG; Sym SJ; Park J; Ahn JY; Cho EK; Kim ST; Shin DB; Lee JH
Int J Clin Exp Pathol; 2012; 5(9):939-47. PubMed ID: 23119111
[TBL] [Abstract][Full Text] [Related]
22. Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer/T-cell lymphoma, nasal type: a multicentre, retrospective analysis.
Kim SJ; Choi JY; Hyun SH; Ki CS; Oh D; Ahn YC; Ko YH; Choi S; Jung SH; Khong PL; Tang T; Yan X; Lim ST; Kwong YL; Kim WS;
Lancet Haematol; 2015 Feb; 2(2):e66-74. PubMed ID: 26687611
[TBL] [Abstract][Full Text] [Related]
23. CD30 expression is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type.
Li P; Jiang L; Zhang X; Liu J; Wang H
BMC Cancer; 2014 Nov; 14():890. PubMed ID: 25429803
[TBL] [Abstract][Full Text] [Related]
24. High IL-6 expression in the tumor microenvironment is associated with poor prognosis of patients with extranodal natural / killer T-cell lymphoma (ENKTL).
Rong Q; Gao Y; Cai Q; Wang X; Bai B; Ping L; He H; Rao H; Zhang Y; Li Z; Cai Q; Jiang W; Huang H
Expert Rev Anticancer Ther; 2021 Jan; 21(1):121-127. PubMed ID: 33397158
[No Abstract] [Full Text] [Related]
25. Appropriate timing to perform an interim
Wang R; Zhang Y; Fan Q; Jiang M; Zou L; Su M
Ann Hematol; 2024 Mar; 103(3):885-892. PubMed ID: 38030892
[TBL] [Abstract][Full Text] [Related]
26. Specific Soft-Tissue Invasion and LMP1 Expression Are Potential Indicators of Extranodal NK/T Cell Lymphoma, Nasal Type.
Jiang M; Lu H; Lu C; Geng X; Jia Y; Wang P; Qian W; Huang H; Shan X
Med Sci Monit; 2018 Oct; 24():7603-7613. PubMed ID: 30356034
[TBL] [Abstract][Full Text] [Related]
27. Development of new prognostic model based on pretreatment βLRI and LLRI for stage IE/IIE upper aerodigestive tract ENKTL, nasal type.
Dai W; Jia B; Yang J; Zhou S; Liu P; He X; Qin Y; Gui L; Zhang C; Han X; Sun Y; Shi Y
Oncotarget; 2017 May; 8(21):34787-34795. PubMed ID: 28410236
[TBL] [Abstract][Full Text] [Related]
28. Prognostic indicators of survival in sinonasal extranodal natural killer/T-cell lymphoma.
Varelas AN; Ganti A; Eggerstedt M; Tajudeen BA
Laryngoscope; 2019 Dec; 129(12):2675-2680. PubMed ID: 30801751
[TBL] [Abstract][Full Text] [Related]
29. [Clinical characteristics and prognostic analysis of advanced-stage extranodal NK/T cell lymphoma].
Wei C; Zhang Y; Wang W; Zhang L; Zhang W; Zhou DB
Zhonghua Xue Ye Xue Za Zhi; 2020 Jun; 41(6):462-468. PubMed ID: 32654458
[No Abstract] [Full Text] [Related]
30. Assessment of the prognostic capacity of pretreatment, interim, and post-therapy (18)F-FDG PET/CT in extranodal natural killer/T-cell lymphoma, nasal type.
Jiang C; Zhang X; Jiang M; Zou L; Su M; Kosik RO; Tian R
Ann Nucl Med; 2015 Jun; 29(5):442-51. PubMed ID: 25801633
[TBL] [Abstract][Full Text] [Related]
31. Extranodal natural killer/T-cell lymphoma with hepatosplenic involvement: a retrospective study of a consecutive 14-year case series.
Zhang YH; Li Z; Zhao S; Zhang WY; Liu QL; Liu WP; Gao LM
Ann Hematol; 2023 Oct; 102(10):2803-2813. PubMed ID: 37434096
[TBL] [Abstract][Full Text] [Related]
32. The prognostic nutritional index predicts survival for patients with extranodal natural killer/T cell lymphoma, nasal type.
Chen KL; Liu YH; Li WY; Chen J; Gu YK; Geng QR; Jiang WQ; Huang HQ; Lin TY; Xia ZJ; Cai QQ
Ann Hematol; 2015 Aug; 94(8):1389-400. PubMed ID: 25869028
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders.
Takahashi E; Ohshima K; Kimura H; Hara K; Suzuki R; Kawa K; Eimoto T; Nakamura S;
Histopathology; 2011 Oct; 59(4):660-71. PubMed ID: 22014047
[TBL] [Abstract][Full Text] [Related]
34. Cutaneous extranodal natural killer (NK) / T - cell lymphoma: A comprehensive clinical features and outcomes analysis of 71 cases.
Jiang L; Li P; Quan Q; Chen P; Qiu H; Zhang B
Leuk Res; 2020 Jan; 88():106284. PubMed ID: 31841860
[TBL] [Abstract][Full Text] [Related]
35. A modified international prognostic index including pretreatment hemoglobin level for early stage extranodal natural killer/T cell lymphoma.
Wang L; Xia ZJ; Lu Y; Wang QX; Niu SQ; Huang HQ; Zhang YJ
Leuk Lymphoma; 2015; 56(11):3038-44. PubMed ID: 25747971
[TBL] [Abstract][Full Text] [Related]
36. Serum aspartate aminotransferase, a novel potential biomarker of prognosis in extranodal natural killer/T cell lymphoma, nasal type.
Yao N; Hou Q; Liang Y; Cao X; Sun B; Wei L; Sun R; Cao J
Cancer Biomark; 2024; 39(4):265-275. PubMed ID: 38108343
[TBL] [Abstract][Full Text] [Related]
37. Extranodal natural killer/T-Cell lymphoma: A population-based comparison of sinonasal and extranasal disease.
Vazquez A; Khan MN; Blake DM; Sanghvi S; Baredes S; Eloy JA
Laryngoscope; 2014 Apr; 124(4):888-95. PubMed ID: 24114591
[TBL] [Abstract][Full Text] [Related]
38. [Influence of Pre-treatment Lymphocyte/Monocyte Ratio and Neutrophil/Lymphocyte Ratio on the Prognosis of Patients with Extranodal NK/T-Cell Lymphoma].
Deng XY; Wang YY; Dang QQ; Liang TS; Zheng YJ; Yang DK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):707-713. PubMed ID: 37356930
[TBL] [Abstract][Full Text] [Related]
39. Nasal endoscopic evaluation and its impact on survival in patients with stage I/II extranodal natural killer/T-cell lymphoma, nasal type.
Cho HJ; Jang MS; Hong SD; Kim SJ; Ahn YC; Oh D; Ko YH; Kim HY; Dhong HJ; Chung SK; Kim WS
Int Forum Allergy Rhinol; 2015 Oct; 5(10):960-6. PubMed ID: 26039707
[TBL] [Abstract][Full Text] [Related]
40. Body mass index as a prognostic factor in patients with extranodal natural killer/T-cell lymphoma, nasal type.
Liu J; Deng YT; Zhang L; Li N; Jiang M; Zou LQ; Jiang Y
Oncotarget; 2016 Nov; 7(47):78159-78167. PubMed ID: 27556299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
